Discounted Cash Flow
Astrana Health, Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $44.0m | $-9.3m | $21.7m | -21.2% | $0.46 |
| 2017 | $357.7m (712.2%) | $25.8m (376.1%) | $49.8m (130.2%) | 7.2% (134.0%) | $1.01 (119.6%) |
| 2018 | $519.9m (45.3%) | $10.8m (-58.0%) | $24.3m (-51.2%) | 2.1% (-71.1%) | $0.33 (-67.3%) |
| 2019 | $560.6m (7.8%) | $14.1m (30.3%) | $12.6m (-48.1%) | 2.5% (20.8%) | $0.41 (24.2%) |
| 2020 | $687.2m (22.6%) | $37.9m (168.2%) | $45.0m (256.2%) | 5.5% (118.8%) | $1.04 (153.7%) |
| 2021 | $773.9m (12.6%) | $73.9m (95.1%) | $51.1m (13.6%) | 9.5% (73.2%) | $1.69 (62.5%) |
| 2022 | $1.1b (47.8%) | $45.2m (-38.8%) | $59.2m (15.8%) | 3.9% (-58.6%) | $1.00 (-40.8%) |
| 2023 | $1.4b (21.2%) | $60.7m (34.4%) | $39.7m (-32.9%) | 4.4% (10.9%) | $1.30 (30.0%) |
| 2024 | $2.0b (46.7%) | $43.1m (-28.9%) | $44.2m (11.3%) | 2.1% (-51.6%) | $0.91 (-30.0%) |
| 2025 | $3.2b (56.4%) | $22.5m (-47.9%) | $104.5m (136.6%) | 0.7% (-66.7%) | $0.46 (-49.5%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.